Cargando…
Complete Removal of Extracellular IgG Antibodies in a Randomized Dose-Escalation Phase I Study with the Bacterial Enzyme IdeS – A Novel Therapeutic Opportunity
IdeS is a streptococcal protease that cleaves IgG antibodies into F(ab’)(2) and Fc fragments with a unique degree of specificity, thereby providing a novel treatment opportunity of IgG-driven autoimmune conditions and antibody mediated transplant rejection. Here we report the results from a first in...
Autores principales: | Winstedt, Lena, Järnum, Sofia, Nordahl, Emma Andersson, Olsson, Andreas, Runström, Anna, Bockermann, Robert, Karlsson, Christofer, Malmström, Johan, Palmgren, Gabriella Samuelsson, Malmqvist, Ulf, Björck, Lars, Kjellman, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4503742/ https://www.ncbi.nlm.nih.gov/pubmed/26177518 http://dx.doi.org/10.1371/journal.pone.0132011 |
Ejemplares similares
-
Imlifidase-generated Single-cleaved IgG: Implications for Transplantation
por: Bockermann, Robert, et al.
Publicado: (2021) -
Streptococcus pyogenes Infection and the Human Proteome with a Special Focus on the Immunoglobulin G-cleaving Enzyme IdeS
por: Karlsson, Christofer A. Q., et al.
Publicado: (2018) -
Safety, immunogenicity, pharmacokinetics, and efficacy of degradation of anti‐HLA antibodies by IdeS (imlifidase) in chronic kidney disease patients
por: Lorant, Tomas, et al.
Publicado: (2018) -
IdeS, a secreted proteinase of Streptococcus pyogenes, is bound to a nuclease at the bacterial surface where it inactivates opsonizing IgG antibodies
por: Frick, Inga-Maria, et al.
Publicado: (2023) -
Streptococcus pyogenes evades adaptive immunity through specific IgG glycan hydrolysis
por: Naegeli, Andreas, et al.
Publicado: (2019)